v3.25.4
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Beginning balance at Dec. 31, 2023 $ 168,870 $ 15 $ 258,231 $ (89,423) $ 47
Beginning balance, shares at Dec. 31, 2023   14,817,696      
Issuance of common stock and pre-funded warrants in connection with the private placement, net of issuance costs 215,333 $ 14 215,319    
Issuance of common stock and pre-funded warrants in connection with the private placement, net of issuance costs, shares   14,500,500      
Issuance of common stock in connection with at-the-market offering ("ATM"), net of issuance costs 39,200 $ 2 39,198    
Issuance of common stock in connection with at-the-market offering ("ATM"), net of issuance costs, shares   1,503,708      
Exercise of pre-funded warrants, shares   210,316      
Exercise of stock options 1,090   1,090    
Exercise of stock options, shares   83,121      
Stock-based compensation expense 12,894   12,894    
Net loss (84,969)     (84,969)  
Unrealized gain on marketable securities 59       59
Ending balance at Dec. 31, 2024 352,477 $ 31 526,732 (174,392) 106
Ending balance, shares at Dec. 31, 2024   31,115,341      
Issuance of common stock and pre-funded warrants in connection with the private placement, net of issuance costs 271,864 $ 8 271,856    
Issuance of common stock and pre-funded warrants in connection with the private placement, net of issuance costs, shares   7,627,879      
Exercise of pre-funded warrants 1 $ 4 (3)    
Exercise of pre-funded warrants, shares   3,833,921      
Exercise of stock options $ 7,903   7,903    
Exercise of stock options, shares 627,148 627,148      
Issuance of common stock under employee stock purchase plan $ 317   317    
Issuance of common stock under employee stock purchase plan, shares   18,801      
Stock-based compensation expense 22,793   22,793    
Net loss (162,337)     (162,337)  
Unrealized gain on marketable securities 383       383
Ending balance at Dec. 31, 2025 $ 493,401 $ 43 $ 829,598 $ (336,729) $ 489
Ending balance, shares at Dec. 31, 2025   43,223,090